141 related articles for article (PubMed ID: 37080716)
1. Novel mRNA Signature for Anti-TNF-α Therapy Primary Response in Patients With Ulcerative Colitis.
Yang X; Shi J; Wang G; Chen H; Ye Y; Zhong J; Wang Z
Inflamm Bowel Dis; 2023 Sep; 29(9):1458-1469. PubMed ID: 37080716
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.
Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA
Front Immunol; 2019; 10():2449. PubMed ID: 31824476
[TBL] [Abstract][Full Text] [Related]
3. Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response.
Ning Y; Lin K; Fang J; Chen X; Hu X; Liu L; Zhao Q; Wang H; Wang F
J Immunol Res; 2023; 2023():7040113. PubMed ID: 36741232
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis.
Tian L; Huang YX; Tian M; Gao W; Chang Q
World J Gastroenterol; 2003 May; 9(5):1028-33. PubMed ID: 12717850
[TBL] [Abstract][Full Text] [Related]
5. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
6. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R
J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818
[TBL] [Abstract][Full Text] [Related]
7. Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study.
Iacucci M; Jeffery L; Acharjee A; Grisan E; Buda A; Nardone OM; Smith SCL; Labarile N; Zardo D; Ungar B; Hunter S; Mao R; Cannatelli R; Shivaji UN; Parigi TL; Reynolds GM; Gkoutos GV; Ghosh S
Inflamm Bowel Dis; 2023 Sep; 29(9):1409-1420. PubMed ID: 36378498
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease.
Goll R; Moe ØK; Johnsen KM; Meyer R; Friestad J; Gundersen MD; Kileng H; Johnsen K; Florholmen JR
BMC Gastroenterol; 2022 Nov; 22(1):464. PubMed ID: 36384462
[TBL] [Abstract][Full Text] [Related]
9. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
10. Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.
Potdar AA; Dube S; Naito T; Li K; Botwin G; Haritunians T; Li D; Casero D; Yang S; Bilsborough J; Perrigoue JG; Denson LA; Daly M; Targan SR; Fleshner P; Braun J; Kugathasan S; Stappenbeck TS; McGovern DPB
Gastroenterology; 2021 Feb; 160(3):809-822.e7. PubMed ID: 33160965
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis.
Hozumi H; Hokari R; Kurihara C; Narimatsu K; Sato H; Sato S; Ueda T; Higashiyama M; Okada Y; Watanabe C; Komoto S; Tomita K; Kawaguchi A; Nagao S; Miura S
Int J Colorectal Dis; 2013 Aug; 28(8):1049-55. PubMed ID: 23377880
[TBL] [Abstract][Full Text] [Related]
12. Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy.
Penrose HM; Iftikhar R; Collins ME; Toraih E; Ruiz E; Ungerleider N; Nakhoul H; Flemington EF; Kandil E; Shah SB; Savkovic SD
Sci Rep; 2021 Apr; 11(1):9010. PubMed ID: 33907256
[TBL] [Abstract][Full Text] [Related]
13. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
[TBL] [Abstract][Full Text] [Related]
15. A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC.
Stucchi A; Reed K; O'Brien M; Cerda S; Andrews C; Gower A; Bushell K; Amar S; Leeman S; Becker J
Inflamm Bowel Dis; 2006 Jul; 12(7):581-7. PubMed ID: 16804395
[TBL] [Abstract][Full Text] [Related]
16. [Effect and mechanism of Bovis Calculus on ulcerative colitis by inhibiting IL-17/IL-17RA/Act1 signaling pathway].
Yuan JM; Lu DN; Wang JJ; Xu Z; Li Y; Ren MH; Li JX; Gong DY; Wang J
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2500-2511. PubMed ID: 37282879
[TBL] [Abstract][Full Text] [Related]
17. Expression of inflammatory genes in the colon of ulcerative colitis patients varies with activity both at the mRNA and protein level.
Verma R; Verma N; Paul J
Eur Cytokine Netw; 2013; 24(3):130-8. PubMed ID: 24197332
[TBL] [Abstract][Full Text] [Related]
18. Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy.
Toedter G; Li K; Sague S; Ma K; Marano C; Macoritto M; Park J; Deehan R; Matthews A; Wu GD; Lewis JD; Arijs I; Rutgeerts P; Baribaud F
Inflamm Bowel Dis; 2012 Aug; 18(8):1399-410. PubMed ID: 22223479
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Sishen Wan on dinitrobenzene sulfonic acid-induced ulcerative colitis and its effect on toll-like receptor 2/interleukin-1 receptor-associated kinase-4/nuclear factor-κB signal pathway.
Zhaohua Z; Rong L; Nana DU; Xiangdong Z
J Tradit Chin Med; 2022 Aug; 42(4):565-575. PubMed ID: 35848973
[TBL] [Abstract][Full Text] [Related]
20. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
